ASH names honorific award recipients
Click Here to Manage Email Alerts
ASH announced this year’s recipients of its honorific awards.
The awards — the most prestigious awards presented by the society — honor hematologists for significant contributions to the field.
“We recognize this year’s diverse group of honorific award recipients for their outstanding contributions to hematology through patient care, research and mentorship,” ASH President Stephanie Lee, MD, MPH, member and associate director of the clinical research division and David and Patricia Giuliani/Oliver Press endowed chair in cancer research at Fred Hutchinson Cancer Research Center, said in a press release. “Each year the society honors individuals who represent some of the most talented, inspirational leaders in our field who have advanced the science and practice of hematology and paved the way for so many others.”
The following individuals will receive their awards at this year’s ASH Annual Meeting and Exposition, scheduled for Dec. 5-8:
• Mohandas Narla, DSc, of New York Blood Center will receive the Wallace H. Coulter Award for Lifetime Achievement in Hematology. Narla will be recognized for his contributions to hematology through research, mentoring, service to ASH and advancement of the field.
• Ari Melnick, MD, of Weill Cornell Medicine and Courtney DiNardo, MD, of The University of Texas MD Anderson Cancer Center will receive the Ernest Beutler Lecture and Prize. The award honors one person for enabling advances in basic science and another for using clinical science or translational research to carry basic science advances through to tangible improvements in patient care. Melnick will be recognized for contributions to the understanding of the epigenetic landscape of hematologic malignancies, and DiNardo will be recognized for clinical trial contributions supporting the approval of several epigenetically active therapies for acute myeloid leukemia.
• Adolfo Ferrando, MD, PhD, of Columbia University Institute for Cancer Genetics will receive the William Dameshek Prize, presented to an early- or mid-career hematologist who made a recent outstanding contribution to the hematology field. Ferrando will be recognized for research into the impact of NOTCH1 mutations on T-cell acute lymphoblastic leukemia.
• Toshio Suda, MD, PhD, of National University of Singapore and International Research Center for Medical Sciences at Kumamoto University, will receive the E. Donnall Thomas Lecture and Prize, which recognizes pioneering research achievements that represent a paradigm shift or significant discovery. Suda will be honored for outstanding contributions to the field of stem cell research.
• Michelle Le Beau, PhD, of University of Chicago and University of Chicago Medicine Comprehensive Cancer Center, and Maria Domenica Cappellini, MD, of University of Milan, will receive the Henry M. Stratton Medal, which honors two senior investigators who made important contributions to basic and clinical/translational hematology research over several years. LeBeau will be recognized for research related to cytogenetic and molecular analysis of hematologic malignancies for the purpose of risk stratification and treatment selection. Cappellini will be recognized for research related to novel therapeutic challenges for thalassemias and sickle cell disease.
• Judith Gasson, PhD, of University of California, Los Angeles, and Wendy Stock, MD, of University of Chicago, will receive ASH Mentor Awards for their contributions to the professional development of several hematology trainees. Mentor Award recipients are chosen because of the significant positive impact they had on their mentees’ careers, and for their contributions to advancing research and patient care in hematology.
• Edward J. Benz Jr., MD, of Dana-Farber Cancer Institute and Harvard Medical School will receive the ASH Award for Leadership in Promoting Diversity. Benz will be recognized for his efforts throughout his career to promote women and underrepresented minority hematologists.